| Drug Name |
Oxazepam |
| Drug ID |
BADD_D01636 |
| Description |
Oxazepam is an intermediate-acting, 3-hydroxybenzodiazepine used in the treatment of alcohol withdrawal and anxiety disorders. Oxazepam, like related 3-hydroxybenzodiazepine [lorazepam], is considered less susceptible to pharmacokinetic variability based on patient-specific factors (e.g. age, liver disease) - this feature is advantageous as compared to other benzodiazepines, and is likely owing in part to oxazepam's relatively simple metabolism.[A203516] It is an active metabolite of both [diazepam] and [temazepam][A39486] and undergoes very little biotransformation following absorption, making it unlikely to participate in pharmacokinetic interactions.[L13895] |
| Indications and Usage |
Oxazepam is indicated for the management of anxiety disorders and for the short-term relief of symptoms of anxiety.[L13895] It may also be used in the management of alcohol withdrawal symptoms.[L13895] |
| Marketing Status |
approved |
| ATC Code |
N05BA04 |
| DrugBank ID |
DB00842
|
| KEGG ID |
D00464
|
| MeSH ID |
D010076
|
| PubChem ID |
4616
|
| TTD Drug ID |
D09LDR
|
| NDC Product Code |
64330-015; 12828-0024; 43353-965; 52817-292; 71610-639; 62584-814; 48087-0087; 72166-009; 43353-980; 52817-291; 62584-813; 0228-2073; 62584-812; 0228-2069; 0228-2067; 52817-290 |
| UNII |
6GOW6DWN2A
|
| Synonyms |
Oxazepam | Serax | Tazepam | Adumbran |
